Literature DB >> 29457584

Immunological Stability of Clostridium difficile Toxins in Clinical Specimens.

Donna M Schora1, Lance R Peterson1, Elena A Usacheva1.   

Abstract

OBJECTIVE The impact of storage on stability and detection of Clostridium difficile toxins in feces is poorly understood. The objective of this study was to investigate the immunological stability of C. difficile toxins in clinical stool specimens under different storage conditions by evaluating this stability using toxin detection by enzyme immunoassay (EIA). METHODS Stool specimens positive for C. difficile infection (CDI) by quantitative polymerase chain reaction (qPCR) were used for EIA testing with the C. difficile Tox A/B II kit. The EIA-positive specimens were stored aerobically under refrigerated (4-10°C) and frozen (-30°C and -80°C) conditions. Measurement of toxin quantity was conducting using optical density (OD) on days 0, 14, 30, 60, 90, and 120 of storage. RESULTS Clostridium difficile toxins demonstrated good detection in undiluted stool specimens by EIA up to 120 days of storage. Good detection of the toxins was observed in diluted samples at refrigerated and -80°C temperatures. Dilution detrimentally affected toxin detection at -30°C. CONCLUSION Storage of undiluted clinical stool specimens at refrigerated, -30°C, and -80°C temperatures for up to 120 days has no discernible effect on the immunological stability of C. difficile cytotoxins. However, storage at -30°C has a detrimental effect on C. difficile toxin stability in diluted specimens. Infect Control Hosp Epidemiol 2018;39:434-438.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29457584     DOI: 10.1017/ice.2018.20

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  4 in total

1.  Ultrasensitive Detection of Clostridioides difficile Toxins A and B by Use of Automated Single-Molecule Counting Technology.

Authors:  Johanna Sandlund; Amelita Bartolome; Anna Almazan; Stanley Tam; Sheryl Biscocho; Salina Abusali; Jeffrey J Bishop; Niamh Nolan; Joel Estis; John Todd; Stephen Young; Fiona Senchyna; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2018-10-25       Impact factor: 5.948

2.  Increased Clinical Specificity with Ultrasensitive Detection of Clostridioides difficile Toxins: Reduction of Overdiagnosis Compared to Nucleic Acid Amplification Tests.

Authors:  Johanna Sandlund; Joel Estis; Phoebe Katzenbach; Niamh Nolan; Kirstie Hinson; Jennifer Herres; Troy Pero; Gwyn Peterson; Jeung-Mi Schumaker; Craig Stevig; Rhonda Warren; Tsubasa West; Siu-Kei Chow
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

3.  Ultrasensitive Detection of Clostridioides difficile Toxins in Stool by Use of Single-Molecule Counting Technology: Comparison with Detection of Free Toxin by Cell Culture Cytotoxicity Neutralization Assay.

Authors:  Glen Hansen; Stephen Young; Alan H B Wu; Emily Herding; Vickie Nordberg; Ray Mills; Christen Griego-Fullbright; Aaron Wagner; Chui Mei Ong; Shawna Lewis; Joseph Yoon; Joel Estis; Johanna Sandlund; Emily Friedland; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

4.  Prospective Evaluation of the mariPOC Test for Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxins A/B.

Authors:  Roosa Savolainen; Juha M Koskinen; Silja Mentula; Janne O Koskinen; Suvi-Sirkku Kaukoranta
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.